DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer. Wu J, Galvan KJ, Bogard RD, Peterson CE, et al. Anticancer Res 2021;41:5393-5403.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu J, Galvan KJ, Bogard RD, Peterson CE, et al. DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer. Anticancer Res 2021;41:5393-5403.
PMID: 34732408